From spring break parties to Mardi Gras, many people remember the last major “normal” thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.
Which Food Allergy Patients Will Benefit Most From Omalizumab?
Data presented at the recent American Academy of Allergy, Asthma & Immunology annual meeting showed that routine injections of omalizumab (Xolair) slashed the severity of
April 9, 2024